Skip to main content
. 2017 Dec 14;92(1):e01070-17. doi: 10.1128/JVI.01070-17

TABLE 3.

Percentages of adults and infants immunized using MF59/rgp120 vaccine (Chiron) with detectable V1V2 IgG at peak immunogenicity

V1V2 IgG Recipients (%) with detectable V1V2 IgG
P
Adults Infants
gp70 B case A V1V2 74 96 0.005
gp70 B case A V1V2 169K 74 93 0.018
gp70 B case A V1V2 mut 3 71 89 0.056
gp70 1086c V1V2 67 87 0.040
AE A244 V1V2 tags 74 83 0.437